pevifoscorvir sodium — Topline data
late Q3 2027
Topline data for both the HBeAg+ and HBeAg- cohorts are expected in late Q3 2027.Source filing
catalyst calendar
ALIGOS THERAPEUTICS INC · Data as of 2026-10-25
late Q3 2027
Topline data for both the HBeAg+ and HBeAg- cohorts are expected in late Q3 2027.Source filing
Nov 7
Date/Time: November 7, 2026 at 1:00pm – 2:00pm MTSource filing
Nov 8
Date/Time: November 8, 2026 at 1:00pm – 2:00pm MTSource filing
Nov 8
Date/Time: November 8, 2026 at 1:00pm – 2:00pm MTSource filing